Keck School Faculty

April W. Armstrong

April W. Armstrong

Professor of Dermatology (Clinical Scholar)
Associate Dean for Clinical Research
Dermatology
HC4 2000 1450 San Pablo Health Sciences Campus Los Angeles

International League of Dermatological Societies (ILDS): International Achievement Award, 2014

American Academy of Dermatology: President’s Award for Volunteerism in Telemedicine, 2011

American Academy of Dermatology: President’s Award for Volunteerism in Telemedicine, 2011

Agency for Healthcare Research and Quality (AHRQ) : K08 Mentored Career Development Award, 2009-2013

Dermatology Foundation: Career Development Award in Health Care Policy , 2009

Women's Dermatologic Society: Academic Research Award, 2009

Dermatology Foundation: Career Development Award in Health Care Policy, 2009

University of California Davis (funded through NIH): K12 Mentored Career Development Award, 2009

21st World Congress of Dermatology: Outstanding Clinical Research Award, 2007

American Telemedicine Association: Innovative Research Award in Teledermatology, 2006-2008

Harvard Medical School : Richard C. Cabot Prize for Excellence in Medical Education, 2004

Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States J Dermatolog Treat. 2023 Dec; 34(1):2200870. . View in PubMed

Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies J Am Acad Dermatol. 2023 Oct; 89(4):832-834. . View in PubMed

Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis using the CorEvitas Psoriasis Registry J Am Acad Dermatol. 2023 Sep 20. . View in PubMed

Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids Am J Clin Dermatol. 2023 Sep 11. . View in PubMed

Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials Am J Clin Dermatol. 2023 Sep 08. . View in PubMed

National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine JAAD Int. 2023 Sep; 12:32-36. . View in PubMed

Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis Dermatol Ther (Heidelb). 2023 Sep 01. . View in PubMed

Shared decision-making and satisfaction with care: a population-based study in patients with acne with skin of colour in the USA Clin Exp Dermatol. 2023 Aug 25; 48(9):1032-1035. . View in PubMed

INDIVIDUAL ARTICLE: Fixed Combination Calcipotriene/Betamethasone (Cal/BDP) Cream: Evaluating the Role of Polyaphron Dispersion (PAD) Technology in Psoriasis Treatment J Drugs Dermatol. 2023 Aug 01; 22(8):SF381621s5-SF381621s10. . View in PubMed

Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis J Drugs Dermatol. 2023 Aug 01; 22(8):736-741. . View in PubMed

No Racial Differences Found in Access to Biologics: A Population-Based Study of Psoriasis Patients in the United States J Drugs Dermatol. 2023 Aug 01; 22(8):835-837. . View in PubMed

Chronic Spontaneous Urticaria: How to Measure It and the Need to Define Treatment Success Dermatol Ther (Heidelb). 2023 Aug; 13(8):1629-1646. . View in PubMed

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis Dermatol Ther (Heidelb). 2023 Jul 31. . View in PubMed

Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies Dermatol Ther (Heidelb). 2023 Jul 25. . View in PubMed

Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: a 2015-2022 prospective cohort analysis of the CorEvitas Psoriasis Registry J Am Acad Dermatol. 2023 Jul 24. . View in PubMed

Interleukin (IL)-17 Versus IL-23 Inhibitors: Which Is Better to Treat Patients With Moderate-to-Severe Psoriasis and Mild Psoriatic Arthritis in Dermatology Clinics? J Rheumatol. 2023 Jul 07.. View in PubMed

The impact of race on mental health outcomes among patients with hidradenitis suppurativa: A population-based study in the United States J Eur Acad Dermatol Venereol. 2023 Jun 16. . View in PubMed

Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel J Drugs Dermatol. 2023 Jun 01; 22(6):588-593. . View in PubMed

Individual Article: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne J Drugs Dermatol. 2023 Jun 01; 22(6):SF350992s7-SF350992s14. . View in PubMed

The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry Adv Ther. 2023 May; 40(5):2493-2508. . View in PubMed

Readability, quality, and comprehensiveness of online health resources for skin cancer in skin of color Int J Dermatol. 2023 Apr 11. . View in PubMed

Brodalumab: 4-Year US Pharmacovigilance Report J Drugs Dermatol. 2023 Apr 01; 22(4):419-422. . View in PubMed

Shared decision-making and satisfaction with care in patients with psoriasis: A population-based study in the United States J Am Acad Dermatol. 2023 Apr 01. . View in PubMed

Impact of Mycobacterium leprae and Mycobacterium lepromatosis on immune reactions and clinical outcomes in Hansen's disease: A single-center retrospective analysis J Am Acad Dermatol. 2023 Mar; 88(3):722-724. . View in PubMed

Trends in Oral Antibiotic Use for Acne Treatment: A Retrospective, Population-Based Study in the United States, 2014 to 2016 J Drugs Dermatol. 2023 Mar 01; 22(3):265-270. . View in PubMed

Evaluating Sentiment, Engagement, and Perception of Biologics Among Patients with Psoriasis and Psoriatic Arthritis on Reddit J Drugs Dermatol. 2023 Mar 01; 22(3):306-309. . View in PubMed

Differences in accessing dermatology offices, primary care offices, and emergency departments between Hispanics and Non-Hispanic White Patients Dermatol Online J. 2023 Feb 15; 29(1). . View in PubMed

Meeting Patient Expectations of Topical Psoriasis Treatment: Evidence Supporting the Use of Fixed-Combination Halobetasol/Tazarotene Lotion J Drugs Dermatol. 2023 Feb 01; 22(2):132-138. . View in PubMed

Real-World Effectiveness of 9-12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry Dermatol Ther (Heidelb). 2023 Feb; 13(2):629-640. . View in PubMed

Dermatol Ther (Heidelb). 2023 Feb; 13(2):487-504. . View in PubMed

Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-1 study): a plain language summary Immunotherapy. 2023 08; 15(12):963-973. . View in PubMed

Perceptions of biologic treatment among hidradenitis suppurativa patients on social media: an analysis of content, engagement, and sentiment Int J Dermatol. 2023 07; 62(7):e379-e382. . View in PubMed

Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances Allergy. 2023 02; 78(2):389-401. . View in PubMed

Effects of online care on functional and psychological outcomes in patients with psoriasis: A randomized controlled trial J Am Acad Dermatol. 2023 02; 88(2):364-370. . View in PubMed

Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial J Am Acad Dermatol. 2023 01; 88(1):29-39. . View in PubMed

Psoriasis and fatigue: a cross-sectional population study of psoriasis patients in the United States using the Medical Expenditure Panel Surveys Br J Dermatol. 2023 02 10; 188(2):301-303. . View in PubMed

Dermatol Online J. 2023 04 15; 29(2). . View in PubMed

Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere) JAMA Dermatol. 2023 02 01; 159(2):182-191. . View in PubMed

Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study J Dermatol Sci. 2023 Jan; 109(1):12-21. . View in PubMed

A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021 J Eur Acad Dermatol Venereol. 2023 Jan; 37 Suppl 1:14-19. . View in PubMed

Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey Dermatology. 2023; 239(4):621-634. . View in PubMed

A Response to: Letter to the Editor Regarding Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis Dermatol Ther (Heidelb). 2022 Dec; 12(12):2867-2870. . View in PubMed

Biologics to breast milk: A cross-sectional study of popular eczema treatment content on TikTok Pediatr Dermatol. 2022 Nov; 39(6):920-922. . View in PubMed

Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3 Dermatol Ther (Heidelb). 2022 Nov; 12(11):2499-2516. . View in PubMed

Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders J Dermatolog Treat. 2022 Nov; 33(7):2991-2996. . View in PubMed

Perspectives on nonmedical switching and the COVID-19 pandemic: a narrative review Am J Manag Care. 2022 Nov 01; 28(11):e417-e425. . View in PubMed

Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity JAMA Dermatol. 2022 Oct 01; 158(10):1210-1212. . View in PubMed

Complementary and alternative medicine use among adults with eczema: A population-based study JAAD Int. 2022 Sep; 8:154-156. . View in PubMed

Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis Dermatol Ther (Heidelb). 2022 Sep; 12(9):2087-2103. . View in PubMed

Undermining during cutaneous wound closure for wounds less than 3 cm in diameter: a randomized split wound comparative effectiveness trial Arch Dermatol Res. 2022 Sep; 314(7):697-703. . View in PubMed

The Association Between Allergic Contact Dermatitis and Erythema Multiforme: A Systematic Review of the Literature Dermatitis. 2022 Sep-Oct 01; 33(5):308-322. . View in PubMed

Int J Dermatol. 2022 Sep; 61(9):1056-1068. . View in PubMed

"I'm Off My Meds": Public Perception of Interactions Between SARS-CoV-2 Vaccines and Anti-Psoriatic Treatments Online J Drugs Dermatol. 2022 Aug 01; 21(8):901-905. . View in PubMed

Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis Dermatol Ther (Heidelb). 2022 Aug; 12(8):1777-1792. . View in PubMed

Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriatic Arthritis Dermatol Ther (Heidelb). 2022 Aug; 12(8):1885-1895. . View in PubMed

International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting J Drugs Dermatol. 2022 Aug 01; 21(8):867-874. . View in PubMed

Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset Dermatol Ther (Heidelb). 2022 Jun; 12(6):1337-1350. . View in PubMed

Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study J Dermatolog Treat. 2022 Jun; 33(4):2317-2324. . View in PubMed

Language proficiency and biologics access: a population study of psoriasis patients in the United States J Dermatolog Treat. 2022 May; 33(3):1413-1417. . View in PubMed

Economic Burden of Chronic Hand Eczema: A Review Am J Clin Dermatol. 2022 May; 23(3):287-300. . View in PubMed

Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis Dermatol Ther (Heidelb). 2022 May; 12(5):1181-1196. . View in PubMed

Who sees you matters: a population study examining topical corticosteroid prescribing patterns between primary care providers and dermatologists for atopic dermatitis J Dermatolog Treat. 2022 May; 33(3):1507-1510. . View in PubMed

Strategies to maximize clinical efficiency while maintaining patient safety during the COVID-19 pandemic: an interview-based study from private practice dermatologists J Dermatolog Treat. 2022 May; 33(3):1503-1506. . View in PubMed

2021 GRAPPA Trainee Symposium: A Summary of Oral and Poster Presentations J Rheumatol. 2022 Apr 15; 4-9. . View in PubMed

Impact of Psoriatic Disease on Quality of Life: Interim Results of a Global Survey Dermatol Ther (Heidelb). 2022 Apr; 12(4):1055-1064. . View in PubMed

SUPPLEMENT ARTICLE: A Novel Drug Delivery Method: Retrometabolic Drug Design J Drugs Dermatol. 2022 Apr 01; 21(4):s5-s10. . View in PubMed

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17 Dermatol Ther (Heidelb). 2022 Mar; 12(3):787-800. . View in PubMed

Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States J Dermatolog Treat. 2022 Mar; 33(2):740-748. . View in PubMed

Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis Dermatol Ther (Heidelb). 2022 Mar; 12(3):753-760. . View in PubMed

Pooled Analysis Demonstrating Superior Patient- Reported Psoriasis Treatment Outcomes for Calcipotriene/ Betamethasone Dipropionate Cream Versus Suspension/Gel J Drugs Dermatol. 2022 Mar 01; 21(3):242-248. . View in PubMed

Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis Dermatol Ther (Heidelb). 2022 Mar; 12(3):727-740. . View in PubMed

Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes Dermatol Ther. 2022 12; 35(12):e15954. . View in PubMed

The Psoriasis Glycome: Differential Expression of Cholesterol Particle Glycans and IgA Glycans Linked to Disease SeverityJ Invest Dermatol. 2022 10; 142(10):2817-2820. e7. . View in PubMed

One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial J Am Acad Dermatol. 2022 10; 87(4):800-806. . View in PubMed

Development of a core outcome set for basal cell carcinoma J Am Acad Dermatol. 2022 09; 87(3):573-581. . View in PubMed

Interrupted subcuticular suture spacing during linear wound closures and the effect on wound cosmesis: a randomized evaluator-blinded split-wound comparative effectiveness trial Br J Dermatol. 2022 09; 187(3):318-323. . View in PubMed

Chronic spontaneous urticaria in the United States: patient characteristics and treatment patterns Int J Dermatol. 2022 08; 61(8):e308-e309. . View in PubMed

Defining Psoriasis Remission Based on Histopathologic and Molecular Criteria: A Systematic Literature ReviewJ Invest Dermatol. 2022 07; 142(7):2026-2029. e4. . View in PubMed

Mental health outcomes and their association to race and ethnicity in acne patients: A population-based study J Am Acad Dermatol. 2022 07; 87(1):140-142. . View in PubMed

Opiate use in dermatology: A population-based study using the National Ambulatory Medical Care Survey in the United States J Am Acad Dermatol. 2022 07; 87(1):174-176. . View in PubMed

2021 GRAPPA Meet the Experts Session: A Summary of Presentations J Rheumatol. 2022 06; 49(6 Suppl 1):32-36. . View in PubMed

Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting J Rheumatol. 2022 06; 49(6 Suppl 1):57-63. . View in PubMed

The atopic dermatitis spectrum disorderRecognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statement. J Dermatolog Treat. 2022 06; 33(4):2397-2399. . View in PubMed

Treatment Goals for Psoriasis as Measured by Patient Benefit Index: Results of a National Psoriasis Foundation Survey Adv Ther. 2022 06; 39(6):2657-2667. . View in PubMed

Pemphigus and bullous pemphigoid in the United States: a 21-year analysis of patient characteristics, treatment patterns, and comorbidities J Dermatolog Treat. 2022 06; 33(4):2383-2385. . View in PubMed

Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting J Rheumatol. 2022 06; 49(6 Suppl 1):40-43. . View in PubMed

Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United States J Am Acad Dermatol. 2022 04; 86(4):748-757. . View in PubMed

Aesthetic outcome of simple cuticular suture distance from the wound edge on the closure of linear wounds on the head and neck: A randomized evaluator blinded split-wound comparative effect trial J Am Acad Dermatol. 2022 04; 86(4):863-867. . View in PubMed

Photoprotection for skin of all color: Consensus and clinical guidance from an expert panel J Am Acad Dermatol. 2022 03; 86(3S):S1-S8. . View in PubMed

Misconceptions of photoprotection in skin of color J Am Acad Dermatol. 2022 03; 86(3S):S9-S17. . View in PubMed

Reply to "Comment on 'Dermatologists in social media: A study on top influencers, posts, and user engagement': Dermatologist influencers on TikTok" J Am Acad Dermatol. 2022 02; 86(2):e75. . View in PubMed

Differences in health care resource utilization and costs for keratinocyte carcinoma among racioethnic groups: A population-based study J Am Acad Dermatol. 2022 02; 86(2):373-378. . View in PubMed

Reply to: "Comment on 'Dermatologists in social media: A study on top influencers, posts, and user engagement'" J Am Acad Dermatol. 2022 02; 86(2):e51. . View in PubMed

Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment Dermatol Ther (Heidelb). 2022 01; 12(1):195-202. . View in PubMed

Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial JAMA Dermatol. 2022 12 01; 158(12):1394-1403. . View in PubMed

Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease JAMA Dermatol. 2022 03 01; 158(3):252-259. . View in PubMed

International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting Dermatology. 2022; 238(3):430-437. . View in PubMed

Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States JAMA Dermatol. 2022 Jan 01; 158(1):68-72. . View in PubMed

Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States JAMA Dermatol. 2022 Jan 01; 158(1):73-78. . View in PubMed

Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis Dermatol Ther (Heidelb). 2022 Jan; 12(1):167-184. . View in PubMed

Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis Am J Clin Dermatol. 2022 Jan; 23(1):1-11. . View in PubMed

Virtual Simulation for Interactive Visualization of 3D Fracture Fixation Biomechanics J Am Acad Orthop Surg. 2022 Jan 01; 30(1):e51-e58. . View in PubMed

Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis Dermatol Ther (Heidelb). 2021 Dec; 11(6):2147-2157. . View in PubMed

Bullous Dermatoses and Depression: A Systematic Review JAMA Dermatol. 2021 Dec 01; 157(12):1487-1495. . View in PubMed

Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis J Dermatolog Treat. 2021 Nov; 32(7):693-700. . View in PubMed

Alopecia areata in the United States: a ten-year analysis of patient characteristics, comorbidities, and treatment patterns Dermatol Online J. 2021 Oct 15; 27(10). . View in PubMed

The Use of Biologics During the COVID-19 Pandemic Dermatol Clin. 2021 Oct; 39(4):545-553. . View in PubMed

INDIVIDUAL ARTICLE: Safety and Tolerability of Topical Agents for Actinic Keratosis: A Systematic Review of Phase 3 Clinical Trials J Drugs Dermatol. 2021 Oct 01; 20(10):s4s4-s14. . View in PubMed

Real-World Satisfaction with Secukinumab in Clearing the Skin of Patients with Plaque Psoriasis through 24 Months of Follow-Up: Results from US Dermatology Electronic Medical Records Dermatol Ther (Heidelb). 2021 Oct; 11(5):1733-1749. . View in PubMed

Childhood atopic dermatitis: outpatient visit trends, demographics, and topical agents in the United States, 1995-2015 Int J Dermatol. 2021 Oct; 60(10):e423-e424. . View in PubMed

Differences in acne therapy prescribing patterns between dermatologists and pediatricians: A population-based study Pediatr Dermatol. 2021 Sep; 38(5):1150-1156. . View in PubMed

Trichotillomania in the United States: An epidemiologic study of patient characteristics, comorbidities, and treatment patterns Dermatol Online J. 2021 Aug 15; 27(8). . View in PubMed

Chronic spontaneous urticaria: a 16-year analysis of pediatric patient demographics, treatment patterns, and comorbidities Dermatol Online J. 2021 Aug 15; 27(8). . View in PubMed

Psoriasis Prevalence in Adults in the United States JAMA Dermatol. 2021 Aug 01; 157(8):940-946. . View in PubMed

Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report J Drugs Dermatol. 2021 Aug 01; 20(8):888-893. . View in PubMed

Anogenital warts and relationship to child sexual abuse: Systematic review and meta-analysis Pediatr Dermatol. 2021 Jul; 38(4):842-850. . View in PubMed

Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis Dermatol Ther (Heidelb). 2021 Jun; 11(3):885-905. . View in PubMed

Association between atopic dermatitis and conjunctivitis in adults: a population-based study in the United States J Dermatolog Treat. 2021 Jun; 32(4):455-459. . View in PubMed

Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting J Rheumatol Suppl. 2021 Jun; 97:4-9. . View in PubMed

Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United States J Dermatolog Treat. 2021 Jun; 32(4):440-445. . View in PubMed

Vitiligo Health Education: A Study of Accuracy and Engagement of Online Educational Materials J Drugs Dermatol. 2021 Jun 01; 20(6):623-629. . View in PubMed

GRAPPA Trainee Symposium 2020: A Summary of Oral and Poster Presentations J Rheumatol Suppl. 2021 Jun; 97:19-23. . View in PubMed

Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting J Rheumatol Suppl. 2021 Jun; 97:10-16. . View in PubMed

Mental health outcomes in White patients versus patients with skin of color with psoriasis Dermatol Online J. 2021 May 15; 27(5). . View in PubMed

ARTICLE: Advances in Oral Isotretinoin Therapy J Drugs Dermatol. 2021 May 01; 20(5):s5-s11. . View in PubMed

J Dermatolog Treat. 2021 May; 32(3):314-320. . View in PubMed

The time to offer treatments for COVID-19 Expert Opin Investig Drugs. 2021 May; 30(5):505-518. . View in PubMed

Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent J Am Acad Dermatol. 2021 Apr; 84(4):1059-1067. . View in PubMed

GRAPPA Trainee Symposium 2020: A Summary of Oral and Poster Presentations J Rheumatol. 2021 Apr 01. . View in PubMed

Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting J Rheumatol. 2021 Mar 15. . View in PubMed

Rosacea videos on social media: A comparison of accuracy, quality, and viewer engagement Dermatol Online J. 2021 Feb 15; 27(2). . View in PubMed

Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting J Rheumatol. 2021 Feb 15. . View in PubMed

Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures J Am Acad Dermatol. 2021 Feb; 84(2):432-470. . View in PubMed

Two-Year US Pharmacovigilance Report on Brodalumab Dermatol Ther (Heidelb). 2021 Feb; 11(1):173-180. . View in PubMed

Brodalumab in an Organ Transplant Recipient With Psoriasis Cutis. 2021 Feb; 107(2):104-106. . View in PubMed

Three-year US. pharmacovigilance report of brodalumab. Dermatol Ther. 2021 11; 34(6):e15105. . View in PubMed

Topical opioid use in dermatologic disease: A systematic review Dermatol Ther. 2021 11; 34(6):e15150. . View in PubMed

Validation of Patient-Reported Psoriasis Diagnosis from a Global Online Research Network J Invest Dermatol. 2021 10; 141(10):2539-2541. . View in PubMed

Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data J Am Acad Dermatol. 2021 09; 85(3):572-581. . View in PubMed

Achievement of the National Psoriasis Foundation treatment targets with ixekizumab: Pooled analyses from 4 clinical studies J Am Acad Dermatol. 2021 08; 85(2):330-336. . View in PubMed

Tapinarof-associated folliculitis is generally mild, self-limiting, and rarely interferes with therapy J Am Acad Dermatol. 2021 07; 85(1):e39-e40. . View in PubMed

The preponderance of evidence supports an aryl hydrocarbon receptor-dependent mechanism of action of tapinarof J Am Acad Dermatol. 2021 07; 85(1):e35-e36. . View in PubMed

National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments J Am Acad Dermatol. 2021 05; 84(5):1254-1268. . View in PubMed

Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience From the Corrona PsA/SpA Registry J Rheumatol. 2021 03; 48(3):376-384. . View in PubMed

Response to Letter to the Editor commenting on: "Dermatologists in social media: A study on top influencers, posts, and user engagement" J Am Acad Dermatol. 2021 03; 84(3):e165. . View in PubMed

A Blueprint for the Conduct of Large, Multisite Trials in Telemedicine J Med Internet Res. 2021 09 20; 23(9):e29511. . View in PubMed

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis N Engl J Med. 2021 12 09; 385(24):2219-2229. . View in PubMed

Corrigendum: Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic Dermatol Online J. 2021 08 15; 27(8). . View in PubMed

Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial Lancet. 2021 02 06; 397(10273):487-498. . View in PubMed

Differences in Depression and Distress Between Acne Patients on Isotretinoin vs Oral Antibiotics J Drugs Dermatol. 2021 02 01; 20(2):172-177. . View in PubMed

Economics of Teledermatology-Does the Math Add Up? JAMA Dermatol. 2021 01 01; 157(1):27-28.. View in PubMed

Psoriasis Lancet. 2021 04 03; 397(10281):1301-1315. . View in PubMed

Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM) Dermatology. 2021; 237(2):151-157. . View in PubMed

Bimekizumab versus Adalimumab in Plaque Psoriasis N Engl J Med. 2021 07 08; 385(2):130-141. . View in PubMed

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1 J Am Acad Dermatol. 2020 Dec; 83(6):1704-1716. . View in PubMed

Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study Am J Clin Dermatol. 2020 Dec; 21(6):881-890. . View in PubMed

Wound eversion versus planar closure for wounds on the face or neck: A randomized split-wound comparative effectiveness trial J Am Acad Dermatol. 2020 Nov; 83(5):1439-1440. . View in PubMed

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic Dermatol Online J. 2020 Oct 15; 26(10). . View in PubMed

Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumab J Dermatolog Treat. 2020 Sep; 31(6):617-623. . View in PubMed

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2 J Dermatolog Treat. 2020 Sep; 31(6):606-614. . View in PubMed

Development of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis: qualitative and quantitative analyses J Dermatolog Treat. 2020 Aug; 31(5):452-459. . View in PubMed

Engaging but inaccurate: A cross-sectional analysis of acne videos on social media from non-health care sources J Am Acad Dermatol. 2020 Aug; 83(2):610-612. . View in PubMed

Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics Dermatol Ther (Heidelb). 2020 Aug; 10(4):615-621. . View in PubMed

Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting J Rheumatol Suppl. 2020 Jun; 96:25-30. . View in PubMed

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies J Am Acad Dermatol. 2020 Jun; 82(6):1445-1486. . View in PubMed

Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative Am J Clin Dermatol. 2020 Jun; 21(3):323-338. . View in PubMed

Where you live matters: Regional differences in health care resource use for psoriasis in the United States J Am Acad Dermatol. 2020 Jun; 82(6):1360-1367. . View in PubMed

Report of the Skin Research Workgroups from the GRAPPA 2019 Annual Meeting J Rheumatol Suppl. 2020 Jun; 96:36-40. . View in PubMed

Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review JAMA. 2020 May 19; 323(19):1945-1960. . View in PubMed

Importance of Complete Skin Clearance in Psoriasis as a Treatment Goal: Implications for Patient-Reported Outcomes J Drugs Dermatol. 2020 May 01; 19(5):487-492. . View in PubMed

Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials J Am Acad Dermatol. 2020 Apr; 82(4):936-945. . View in PubMed

Recapture Rate of Brodalumab in Patients With a Lapse in Treatment J Drugs Dermatol. 2020 Apr 01; 19(4):384-387. . View in PubMed

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure Dermatol Ther (Heidelb). 2020 Feb; 10(1):133-150. . View in PubMed

Report from the International Dermatology Outcome Measures Initiative J Investig Dermatol Symp Proc. 2020 11; 20(1):S80-S83. . View in PubMed

Dermatologists in social media: A study on top influencers, posts, and user engagement J Am Acad Dermatol. 2020 11; 83(5):1452-1455. . View in PubMed

A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)J Invest Dermatol. 2020 09; 140(9):1784-1793. e2. . View in PubMed

Comparison of 2-Octylcyanoacrylate Versus 5-0 Fast-Absorbing Gut During Linear Wound Closures and the Effect on Wound Cosmesis Dermatol Surg. 2020 05; 46(5):628-634. . View in PubMed

Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis JAMA Dermatol. 2020 03 01; 156(3):258-269. . View in PubMed

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial JAMA Dermatol. 2020 04 01; 156(4):411-420. . View in PubMed

Oral Tetracyclines and Acne: A Systematic Review for Dermatologists J Drugs Dermatol. 2020 11 01; 19(11):s6-s13. . View in PubMed

Association Between the Mental Health of Patients With Psoriasis and Their Satisfaction With Physicians JAMA Dermatol. 2020 07 01; 156(7):754-762. . View in PubMed

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients J Am Acad Dermatol. 2020 Jan; 82(1):161-201. . View in PubMed

Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials J Am Acad Dermatol. 2020 Jan; 82(1):54-61. . View in PubMed

Dermal suture only versus layered closure: A randomized, split wound comparative effectiveness trial J Am Acad Dermatol. 2019 Dec; 81(6):1346-1352. . View in PubMed

Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study J Am Acad Dermatol. 2019 Oct; 81(4):923-930. . View in PubMed

Factors Influencing Sleep Difficulty and Sleep Quantity in the Citizen Pscientist Psoriatic Cohort Dermatol Ther (Heidelb). 2019 Sep; 9(3):511-523. . View in PubMed

Novel Tretinoin 0 05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population J Drugs Dermatol. 2019 Sep 01; 18(9):910-916. . View in PubMed

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy J Am Acad Dermatol. 2019 Sep; 81(3):775-804. . View in PubMed

Comparison of physical and mental functioning among moderate-to-severe psoriasis patients on biologic versus oral therapy Arch Dermatol Res. 2019 Aug; 311(6):453-460. . View in PubMed

Real-world experience of calcipotriene and betamethasone dipropionate foam 0005%/0. 064% in the treatment of adults with psoriasis in the United States. J Dermatolog Treat. 2019 Aug; 30(5):454-460. . View in PubMed

An unusual spiculated presentation of follicular porokeratosis Dermatol Online J. 2019 Jul 15; 25(7). . View in PubMed

Use of 5-0 Fast Absorbing Gut versus 6-0 Fast Absorbing Gut during cutaneous wound closure on the head and neck: A randomized evaluator-blinded split-wound comparative effectiveness trial J Am Acad Dermatol. 2019 Jul; 81(1):213-218. . View in PubMed

Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting J Rheumatol Suppl. 2019 Jun; 95:11-19. . View in PubMed

Report of the Skin Research Workgroups from the GRAPPA 2018 Annual Meeting J Rheumatol Suppl. 2019 Jun; 95:28-32. . View in PubMed

Economic burden of cutaneous infections in children and adults with atopic dermatitis Pediatr Dermatol. 2019 May; 36(3):303-310. . View in PubMed

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics J Am Acad Dermatol. 2019 Apr; 80(4):1029-1072. . View in PubMed

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities J Am Acad Dermatol. 2019 Apr; 80(4):1073-1113. . View in PubMed

Comparison of mental health outcomes among adults with psoriasis on biologic versus oral therapies: a population-based study J Dermatolog Treat. 2019 Mar; 30(2):135-140. . View in PubMed

Clinical Goals and Barriers to Effective Psoriasis Care Dermatol Ther (Heidelb). 2019 Mar; 9(1):5-18. . View in PubMed

Suicidality among psoriasis patients: a critical evidence synthesis G Ital Dermatol Venereol. 2019 Feb; 154(1):56-63. . View in PubMed

Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies Am J Clin Dermatol. 2019 Feb; 20(1):155-164. . View in PubMed

Quality of life among dermatology patients: a systematic review of investigations using qualitative methods G Ital Dermatol Venereol. 2019 Feb; 154(1):72-78. . View in PubMed

Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial J Dermatolog Treat. 2019 Feb; 30(1):27-34. . View in PubMed

Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 StudyJ Invest Dermatol. 2019 12; 139(12):2437-2446. e1. . View in PubMed

Access to Dermatological Care with an Innovative Online Model for Psoriasis Management: Results from a Randomized Controlled Trial Telemed J E Health. 2019 07; 25(7):619-627. . View in PubMed

Anti-tumor necrosis factor agents in sarcoidosis: A systematic review of efficacy and safety Semin Arthritis Rheum. 2019 06; 48(6):1093-1104. . View in PubMed

Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease Dermatol Surg. 2019 05; 45(5):640-649. . View in PubMed

Online Care Versus In-Person Care for Improving Quality of Life in Psoriasis: A Randomized Controlled Equivalency Trial J Invest Dermatol. 2019 05; 139(5):1037-1044. . View in PubMed

A provider global assessment quality measure for clinical practice for inflammatory skin disorders J Am Acad Dermatol. 2019 03; 80(3):823-828. . View in PubMed

Exploring Mental Disorders in Patients With Skin Diseases JAMA Dermatol. 2019 06 01; 155(6):660-661. . View in PubMed

Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry RMD Open. 2019; 5(1):e000867. . View in PubMed

Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis PLoS One. 2019; 14(1):e0210517. . View in PubMed

Comparison of Running Cutaneous Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis of the Face and Neck: A Randomized Clinical Trial JAMA Dermatol. 2019 03 01; 155(3):321-326. . View in PubMed

Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial Lancet. 2019 09 07; 394(10201):831-839. . View in PubMed

Problematic Strength of the Association Between Atopic Dermatitis and Suicidality-Reply JAMA Dermatol. 2019 05 01; 155(5):638. . View in PubMed

Association Between Atopic Dermatitis and Suicidality: A Systematic Review and Meta-analysis JAMA Dermatol. 2019 02 01; 155(2):178-187. . View in PubMed

Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Am J Clin Dermatol. 2018 Dec; 19(6):879-886. . View in PubMed

Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative Arch Dermatol Res. 2018 Nov; 310(9):701-710. . View in PubMed

Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts Dermatol Ther (Heidelb). 2018 Sep; 8(3):405-423. . View in PubMed

Oral small molecules for psoriasis Semin Cutan Med Surg. 2018 Sep; 37(3):163-166. . View in PubMed

Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting J Rheumatol Suppl. 2018 Jun; 94:54-61. . View in PubMed

Psoriasis in solid organ transplant patients: best practice recommendations from The Medical Board of the National Psoriasis Foundation J Dermatolog Treat. 2018 Jun; 29(4):329-333. . View in PubMed

Report of the Skin Research Working Groups from the GRAPPA 2017 Annual Meeting J Rheumatol Suppl. 2018 Jun; 94:40-43. . View in PubMed

Using qualitative methods to understand factors contributing to patient satisfaction among dermatology patients: a systematic review J Dermatolog Treat. 2018 May; 29(3):290-294. . View in PubMed

Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review Arch Dermatol Res. 2018 May; 310(4):271-319. . View in PubMed

J Dermatolog Treat. 2018 May; 29(3):295-299. . View in PubMed

In vitro cytocompatibility evaluation of poly(octamethylene citrate) monomers toward their use in orthopedic regenerative engineering Bioact Mater. 2018 Mar; 3(1):19-27. . View in PubMed

Treating to Target-A Realistic Goal in Psoriasis? Semin Cutan Med Surg. 2018 Feb; 37(2S):S44-S47.. View in PubMed

The Evolving Landscape of Psoriasis Treatment Semin Cutan Med Surg. 2018 Feb; 37(2S):S39-S43. . View in PubMed

Common and Not-So-Common Comorbidities of Psoriasis Semin Cutan Med Surg. 2018 Feb; 37(2S):S48-S51. . View in PubMed

Practical Strategies for Optimizing Management of Psoriasis Semin Cutan Med Surg. 2018 Feb; 37(2S):S52-S55. . View in PubMed

Teledermatology in the United States: An Update in a Dynamic Era Telemed J E Health. 2018 09; 24(9):691-697. . View in PubMed

Number needed to treat and costs per responder among biologic treatments for moderate-to-severe psoriasis: a network meta-analysis Curr Med Res Opin. 2018 07; 34(7):1325-1333. . View in PubMed

Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial Circ Cardiovasc Imaging. 2018 06; 11(6):e007394. . View in PubMed

Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation J Am Acad Dermatol. 2018 02; 78(2):383-394. . View in PubMed

Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis J Am Acad Dermatol. 2018 02; 78(2):395-402. . View in PubMed

Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review JAMA Dermatol. 2018 08 01; 154(8):934-950. . View in PubMed

Characteristics of Medical Liability Claims Against Dermatologists From 1991 Through 2015 JAMA Dermatol. 2018 02 01; 154(2):160-166. . View in PubMed

Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in Psoriasis Dermatology. 2018; 234(5-6):157-165. . View in PubMed

Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM) Dermatology. 2018; 234(3-4):112-119. . View in PubMed

Adverse Medical Conditions Across Treatment Options in Patients With Psoriasis: A Claims-Based Analysis J Drugs Dermatol 2018 11 01; 17(11):1211-1218. . View in PubMed

Effectiveness of Online vs In-Person Care for Adults With Psoriasis: A Randomized Clinical Trial JAMA Netw Open. 2018 10 05; 1(6):e183062. . View in PubMed

Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization BMC Dermatol. 2018 06 28; 18(1):4. . View in PubMed

Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials JAMA Dermatol. 2018 10 01; 154(10):1137-1144. . View in PubMed

Psoriasis and wound healing outcomes: A retrospective cohort study examining wound complications and antibiotic use Dermatol Online J. 2017 Nov 15; 23(11). . View in PubMed

Rethinking costs of psoriasis: 10% of patients account for nearly 40% of healthcare expenditures among enrollees with psoriasis in a US. health plan. J Dermatolog Treat. 2017 Nov; 28(7):613-622. . View in PubMed

Psoriasis and suicidality: A systematic review and meta-analysisJ Am Acad Dermatol. 2017 Sep; 77(3):425-440. e2. . View in PubMed

Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) - clinical trial and the SAPS - real world patient-reported outcomes J Dermatolog Treat. 2017 Sep; 28(6):505-514. . View in PubMed

International Dermatology Outcome Measures (IDEOM) Group 2016 New York Meeting: Meeting Summary and Data from the Psoriasis Working Group J Drugs Dermatol. 2017 Aug 01; 16(8):770-777. . View in PubMed

Drivers of Healthcare Costs Among the Costliest Patients With Psoriasis Over Three Years in a United States Health Plan J Drugs Dermatol. 2017 Jul 01; 16(7):651-658. . View in PubMed

Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United States Clin Drug Investig. 2017 May; 37(5):493-501. . View in PubMed

Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasis J Dermatolog Treat. 2017 May; 28(3):200-205. . View in PubMed

Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data Dermatol Ther (Heidelb). 2017 Mar; 7(1):97-109. . View in PubMed

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial J Am Acad Dermatol. 2017 Mar; 76(3):418-431. . View in PubMed

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis J Am Acad Dermatol. 2017 Feb; 76(2):290-298. . View in PubMed

The International Dermatology Outcome Measures (IDEOM) Initiative: A Review and Update J Drugs Dermatol. 2017 Feb 01; 16(2):119-124. . View in PubMed

Direct-Access Online Care for the Management of Atopic Dermatitis: A Randomized Clinical Trial Examining Patient Quality of Life Telemed J E Health. 2017 09; 23(9):726-732. . View in PubMed

Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting J Rheumatol. 2017 05; 44(5):674-678. . View in PubMed

Defining Outcome Measures for Psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting J Rheumatol. 2017 05; 44(5):701-702. . View in PubMed

Proceedings of the GRAPPA 2016 Retreat J Rheumatol. 2017 05; 44(5):668-673. . View in PubMed

Antibiotic Resistance in Acne Treatment JAMA Dermatol. 2017 08 01; 153(8):810-811. . View in PubMed

An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies PLoS One. 2017; 12(7):e0181039. . View in PubMed

National Psoriasis Foundation Priorities for Patient-Centered Research: Proceedings from the 2016 Conference J Psoriasis Psoriatic Arthritis. 2017; 2(3):73-80. . View in PubMed

Psoriasis JAMA Dermatol. 2017 09 01; 153(9):956. . View in PubMed

Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms Rheumatol Int. 2017 Jan; 37(1):97-105. . View in PubMed

Real-World Clinical Experience With Apremilast in a Large US Retrospective Cohort Study of Patients With Moderate to Severe Plaque Psoriasis J Drugs Dermatol. 2017 12 01; 16(12):1240-1245. . View in PubMed

Relationship between psoriasis and metabolic syndrome: a systematic review G Ital Dermatol Venereol. 2016 Dec; 151(6):663-677. . View in PubMed

Body Region Involvement and Quality of Life in Psoriasis: Analysis of a Randomized Controlled Trial of Adalimumab Am J Clin Dermatol. 2016 Dec; 17(6):691-699. . View in PubMed

Effect of a Pre-Treatment Educational Video in Improving Patient Satisfaction with 5-Fluorouracil Treatment for Actinic Keratoses: A Randomized Controlled Trial Dermatol Ther (Heidelb). 2016 Dec; 6(4):675-681. . View in PubMed

Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: A systematic review J Am Acad Dermatol. 2016 Nov; 75(5):906-917. . View in PubMed

Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naïve patients with psoriasis J Am Acad Dermatol. 2016 Oct; 75(4):740-746. . View in PubMed

From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritisJ Am Acad Dermatol. 2016 Oct; 75(4):798-805. e7. . View in PubMed

Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study J Drugs Dermatol. 2016 Oct 01; 15(10):1192-1196. . View in PubMed

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa N Engl J Med. 2016 Aug 04; 375(5):422-34. . View in PubMed

A Clinician's Guide to the Diagnosis and Treatment of Candidiasis in Patients with Psoriasis Am J Clin Dermatol. 2016 Aug; 17(4):329-36. . View in PubMed

Perceptions of Aesthetic Outcome of Linear vs Multiple Z-Plasty Scars in a National Survey JAMA Facial Plast Surg. 2016 Jul 01; 18(4):263-7. . View in PubMed

Secukinumab: Review of Clinical Evidence from the Pivotal Studies ERASURE, FIXTURE, and CLEAR J Clin Aesthet Dermatol. 2016 Jun; 9(6 Suppl 1):S7-S12. . View in PubMed

The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis J Clin Aesthet Dermatol. 2016 Jun; 9(6 Suppl 1):S3-S6. . View in PubMed

Secukinumab in the Treatment of Palmoplantar, Nail, Scalp, and Pustular Psoriasis J Clin Aesthet Dermatol. 2016 Jun; 9(6 Suppl 1):S12-S16. . View in PubMed

Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners J Cutan Med Surg. 2016 May; 20(3):196-206. . View in PubMed

Dermatol Surg. 2016 Mar; 42(3):335-51. . View in PubMed

US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey Am J Clin Dermatol. 2016 Feb; 17(1):87-97. . View in PubMed

Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical Trials Am J Clin Dermatol. 2016 Feb; 17(1):79-86. . View in PubMed

Practice Guidelines for Teledermatology Telemed J E Health. 2016 12; 22(12):981-990. . View in PubMed

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis Arthritis Rheumatol. 2016 05; 68(5):1060-71. . View in PubMed

International Dermatology Outcome Measures Initiative as Applied to Psoriatic Disease Outcomes: An Update J Rheumatol. 2016 05; 43(5):959-60. . View in PubMed

Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical Trials JAMA Dermatol. 2016 06 01; 152(6):661-9. . View in PubMed

Screening Recommendations for Hepatitis B Virus Infection JAMA Dermatol. 2016 05 01; 152(5):565-6. . View in PubMed

RAC1 activation drives pathologic interactions between the epidermis and immune cells J Clin Invest. 2016 07 01; 126(7):2661-77. . View in PubMed

Dietary supplementation with Bifidobacterium longum subspinfantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial. Trials. 2016 07 22; 17(1):340. . View in PubMed

The Role of Biologic Therapies in Dermatology Med Clin North Am. 2015 Nov; 99(6):1183-94. . View in PubMed

A case of Kaposi sarcoma in an immunocompetent, heterosexual Irish man: a discussion of etiology and viral transmission Dermatol Online J. 2015 Oct 16; 21(10). . View in PubMed

Effectiveness of a novel interactive health care education tool on clinical outcomes and quality of life in acne patients: A randomized controlled pilot study J Dermatolog Treat. 2015 Oct; 26(5):435-9. . View in PubMed

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis N Engl J Med. 2015 Oct; 373(14):1318-28. . View in PubMed

Response to: "is tonsillectomy a therapeutic option for plaque-type psoriasis? ". J Am Acad Dermatol. 2015 Oct; 73(4):e155.. View in PubMed

Effect of Automated Online Counseling on Clinical Outcomes and Quality of Life Among Adolescents With Acne Vulgaris: A Randomized Clinical Trial JAMA Dermatol. 2015 Sep; 151(9):970-5. . View in PubMed

Screening Recommendations for Chlamydia and Gonorrhea JAMA Dermatol. 2015 Sep; 151(9):1014-6. . View in PubMed

Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burdenJ Am Acad Dermatol. 2015 Sep; 73(3):383-91. e1. . View in PubMed

Essential Truths for the Care and Management of Moderate-to-Severe Psoriasis J Drugs Dermatol. 2015 Aug; 14(8):805-12. . View in PubMed

Effect of Adhesive Strips and Dermal Sutures vs Dermal Sutures Only on Wound Closure: A Randomized Clinical Trial JAMA Dermatol. 2015 Aug; 151(8):862-7. . View in PubMed

Successful treatment of psoriasis with ustekinumab in patients with multiple sclerosis Dermatol Online J. 2015 Jul 15; 21(7). . View in PubMed

Int J Dermatol. 2015 Jul; 54(7):807-16. . View in PubMed

Psoriasis and risk of diabetes-associated microvascular and macrovascular complicationsJ Am Acad Dermatol. 2015 Jun; 72(6):968-77. e2. . View in PubMed

The global burden of psoriatic skin disease Br J Dermatol. 2015 Jun; 172(6):1665-1668. . View in PubMed

Economic Burden of Psoriasis in the United States: A Systematic Review JAMA Dermatol. 2015 Jun; 151(6):651-8. . View in PubMed

Set-back versus buried vertical mattress suturing: results of a randomized blinded trial J Am Acad Dermatol. 2015 Apr; 72(4):674-80. . View in PubMed

Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation JAMA Dermatol. 2015 Apr; 151(4):432-8. . View in PubMed

Purse-string suture vs second intention healing: results of a randomized, blind clinical trial JAMA Dermatol. 2015 Mar; 151(3):265-70. . View in PubMed

Participant satisfaction with appearance-based versus health-based educational videos promoting sunscreen use: a randomized controlled trial Dermatol Online J. 2015 Feb 16; 21(2). . View in PubMed

Comparing the effectiveness of automated online counseling to standard web-based education on improving acne knowledge: a randomized controlled trial Am J Clin Dermatol. 2015 Feb; 16(1):55-60. . View in PubMed

The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology J Am Acad Dermatol. 2015 Feb; 72(2):345-8. . View in PubMed

Effect of tonsillectomy on psoriasis: a systematic review J Am Acad Dermatol. 2015 Feb; 72(2):261-75. . View in PubMed

Patient-centered, direct-access online care for management of atopic dermatitis: a randomized clinical trial JAMA Dermatol. 2015 Feb; 151(2):154-60. . View in PubMed

An evidence-based review of the mechanism of action, efficacy, and safety of biologic therapies in the treatment of psoriasis and psoriatic arthritis Curr Med Chem. 2015; 22(16):1930-42. . View in PubMed

The global burden of disease associated with alopecia areata Br J Dermatol. 2015; 172(5):1424-6. . View in PubMed

Comparative prevalence of complementary and alternative medicine use among outpatients in dermatology and primary care clinics JAMA Dermatol. 2014 Dec; 150(12):1363-5. . View in PubMed

Efficacy of photodynamic therapy vs other interventions in randomized clinical trials for the treatment of actinic keratoses: a systematic review and meta-analysis JAMA Dermatol. 2014 Dec; 150(12):1281-8. . View in PubMed

Effective management of psoriasis and psoriatic arthritis: insights on current and emerging therapies and enhanced professional collaboration Semin Arthritis Rheum. 2014 Dec; 44(3):e7-8. . View in PubMed

Public perception of dermatologists and comparison with other medical specialties: results from a national survey J Am Acad Dermatol. 2014 Nov; 71(5):875-81. . View in PubMed

Pre-bisection of a single skin biopsy does not produce technically inadequate specimens for direct immunofluorescence: a review of 3450 specimens J Cutan Pathol. 2014 Nov; 41(11):890-2. . View in PubMed

Treatments for nail psoriasis: a systematic review by the GRAPPA Nail Psoriasis Work Group J Rheumatol. 2014 Nov; 41(11):2306-14. . View in PubMed

Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2 J Dermatolog Treat. 2014 Oct; 25(5):401-8. . View in PubMed

Psoriasis provoked or exacerbated by medications: identifying culprit drugs JAMA Dermatol. 2014 Sep; 150(9):963. . View in PubMed

Psoriasis and dyslipidemia: a population-based study analyzing the National Health and Nutrition Examination Survey (NHANES) J Eur Acad Dermatol Venereol. 2014 Aug; 28(8):1109-12. . View in PubMed

Evaluation and management of adult shoulder pain: a focus on rotator cuff disorders, acromioclavicular joint arthritis, and glenohumeral arthritis Med Clin North Am. 2014 Jul; 98(4):755-75xii. . View in PubMed

Electrobrasion vsmanual dermabrasion: a randomized, double-blind, comparative effectiveness trial. Br J Dermatol. 2014 Jul; 171(1):124-9. . View in PubMed

Metabolomic analysis using porcine skin: a pilot study of analytical techniques Dermatol Online J. 2014 Jun 15; 20(6). . View in PubMed

Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children Benef Microbes. 2014 Jun 01; 5(2):151-60. . View in PubMed

Psoriasis and psoriatic arthritis educational initiatives: an update from the 2013 GRAPPA Annual Meeting J Rheumatol. 2014 Jun; 41(6):1240-3. . View in PubMed

Outcomes research in psoriasis and psoriatic arthritis using large databases and research networks: a report from the GRAPPA 2013 Annual Meeting J Rheumatol. 2014 Jun; 41(6):1233-6. . View in PubMed

The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meeting J Rheumatol. 2014 Jun; 41(6):1227-9. . View in PubMed

Strategies to maximize treatment success in moderate to severe psoriasis: establishing treatment goals and tailoring of biologic therapies Semin Cutan Med Surg. 2014 Jun; 33(2):91-7. . View in PubMed

Dermatol Surg. 2014 Jun; 40(6):671-8. . View in PubMed

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: a randomized controlled trial J Am Acad Dermatol. 2014 Apr; 70(4):665-669. . View in PubMed

Videos to influence: a systematic review of effectiveness of video-based education in modifying health behaviors J Behav Med. 2014 Apr; 37(2):218-33. . View in PubMed

Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis Drugs. 2014 Mar; 74(4):423-41. . View in PubMed

Diet and nutrition in psoriasis: analysis of the National Health and Nutrition Examination Survey (NHANES) in the United States J Eur Acad Dermatol Venereol. 2014 Mar; 28(3):327-32. . View in PubMed

Psoriasis prevalence among adults in the United States J Am Acad Dermatol. 2014 Mar; 70(3):512-6. . View in PubMed

Surgeon error and slide quality during Mohs micrographic surgery: is there a relationship with tumor recurrence? J Am Acad Dermatol. 2014 Feb; 70(2):386-7.. View in PubMed

Antidrug antibodies in psoriasis: a systematic review Br J Dermatol. 2014 Feb; 170(2):261-73. . View in PubMed

Psoriasis and Sexual Behavior in Men: examination of the National Health and Nutrition Examination Survey (NHANES) in the United States J Sex Med. 2014 Feb; 11(2):394-400. . View in PubMed

Psoriasis and smoking: a systematic review and meta-analysis Br J Dermatol. 2014 Feb; 170(2):304-14. . View in PubMed

Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis F1000Res. 2014; 3:248. . View in PubMed

JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis J Immunol Res. 2014; 2014:283617. . View in PubMed

Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review Curr Pharm Des. 2014; 20(4):500-12. . View in PubMed

Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review Curr Pharm Des. 2014; 20(4):513-28. . View in PubMed

Psoriasis, electrocardiographic characteristics, and incidence of atrial fibrillation Arch Dermatol Res. 2013 Dec; 305(10):891-7. . View in PubMed

Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response Expert Rev Clin Immunol. 2013 Oct; 9(10):949-58. . View in PubMed

Association between psoriasis and viral infections in the United States: focusing on hepatitis B, hepatitis C and human immunodeficiency virus J Eur Acad Dermatol Venereol. 2013 Oct; 27(10):1312-6. . View in PubMed

Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011 JAMA Dermatol. 2013 Oct; 149(10):1180-5. . View in PubMed

Tumor necrosis factor inhibitors and myocardial infarction in psoriasis--reply JAMA. 2013 Sep 11; 310(10):1076. . View in PubMed

Evaluation criteria for mobile teledermatology applications and comparison of major mobile teledermatology applications Telemed J E Health. 2013 Sep; 19(9):678-82. . View in PubMed

Immunology of atopic dermatitis: novel insights into mechanisms and immunomodulatory therapies Semin Cutan Med Surg. 2013 Sep; 32(3):132-9. . View in PubMed

Corticosteroids and wound healing: clinical considerations in the perioperative period Am J Surg. 2013 Sep; 206(3):410-7. . View in PubMed

Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting J Rheumatol. 2013 Aug; 40(8):1434-7. . View in PubMed

Psoriasis and psoriatic arthritis video project: an update from the 2012 GRAPPA annual meeting J Rheumatol. 2013 Aug; 40(8):1455-6. . View in PubMed

Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting J Rheumatol. 2013 Aug; 40(8):1438-41. . View in PubMed

Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting J Rheumatol. 2013 Aug; 40(8):1428-33. . View in PubMed

Surgeon error and slide quality during Mohs micrographic surgery: is there a relationship with tumor recurrence? J Am Acad Dermatol. 2013 Jul; 69(1):105-11.. View in PubMed

Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States Pediatr Dermatol. 2013 Jul-Aug; 30(4):424-8. . View in PubMed

Reply: To PMID 22459360 J Am Acad Dermatol. 2013 Jun; 68(6):1042-3. . View in PubMed

Access to health care in patients with psoriasis and psoriatic arthritis: data from National Psoriasis Foundation survey panels JAMA Dermatol. 2013 Jun; 149(6):717-21. . View in PubMed

Do TNF inhibitors reduce the risk of myocardial infarction in psoriasis patients? JAMA. 2013 May 15; 309(19):2043-4.. View in PubMed

Postoperative preferences in cutaneous surgery: a patient-centered investigation from an academic dermatologic surgery practice Dermatol Surg. 2013 May; 39(5):773-8. . View in PubMed

Standardizing training for psoriasis measures: effectiveness of an online training video on Psoriasis Area and Severity Index assessment by physician and patient raters JAMA Dermatol. 2013 May; 149(5):577-82. . View in PubMed

Prevalence of pilomatricoma in Turner syndrome: findings from a multicenter study JAMA Dermatol. 2013 May; 149(5):559-64. . View in PubMed

Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies J Am Heart Assoc. 2013 Apr 04; 2(2):e000062. . View in PubMed

Clinical and histologic diagnostic guidelines for psoriasis: a critical review Clin Rev Allergy Immunol. 2013 Apr; 44(2):166-72. . View in PubMed

Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies J Am Acad Dermatol. 2013 Apr; 68(4):654-662. . View in PubMed

Improving patient education with an eczema action plan: a randomized controlled trial JAMA Dermatol. 2013 Apr; 149(4):481-3. . View in PubMed

The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies J Hypertens. 2013 Mar; 31(3):433-42; discussion 442-3. . View in PubMed

The association between psoriasis and dyslipidaemia: a systematic review Br J Dermatol. 2013 Mar; 168(3):486-95. . View in PubMed

Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids JAMA Dermatol. 2013 Mar; 149(3):350-5. . View in PubMed

Psoriasis and sexual behavior in US. women: an epidemiologic analysis using the National Health and Nutrition Examination Survey (NHANES). J Sex Med. 2013 Feb; 10(2):326-32. . View in PubMed

Crowdsourcing for data collection: a pilot study comparing patient-reported experiences and clinical trial data for the treatment of seborrheic dermatitis Skin Res Technol. 2013 Feb; 19(1):55-7. . View in PubMed

Separate- versus same-day preoperative consultation in dermatologic surgery: a patient-centered investigation in an academic practice Dermatol Surg. 2013 Feb; 39(2):240-7. . View in PubMed

Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis JAMA Dermatol. 2013 Jan; 149(1):84-91. . View in PubMed

The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies Nutr Diabetes. 2012 Dec 03; 2:e54. . View in PubMed

Harnessing the power of crowds: crowdsourcing as a novel research method for evaluation of acne treatments Am J Clin Dermatol. 2012 Dec 01; 13(6):405-16. . View in PubMed

Power of crowdsourcing: novel methods of data collection in psoriasis and psoriatic arthritisJ Am Acad Dermatol. 2012 Dec; 67(6):1273-1281. e9. . View in PubMed

J Am Acad Dermatol. 2012 Dec; 67(6):1136-42. . View in PubMed

Psoriasis and autoimmune disorders: a review of the literature J Am Acad Dermatol. 2012 Nov; 67(5):1076-9. . View in PubMed

State of teledermatology programs in the United States J Am Acad Dermatol. 2012 Nov; 67(5):939-44. . View in PubMed

Psoriasis and psoriatic arthritis video project: an update from the GRAPPA 2011 annual meeting J Rheumatol. 2012 Nov; 39(11):2198-200. . View in PubMed

Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting J Rheumatol. 2012 Nov; 39(11):2204-10. . View in PubMed

Congenital self-healing reticulohistiocytosis: concern for a poor prognosis Dermatol Online J. 2012 Oct 15; 18(10):2. . View in PubMed

Crowdsourcing in eczema research: a novel method of data collection J Drugs Dermatol. 2012 Oct; 11(10):1153-5. . View in PubMed

Teledermatology operational considerations, challenges, and benefits: the referring providers' perspective Telemed J E Health. 2012 Oct; 18(8):580-4. . View in PubMed

Perceptions of expertise in cutaneous surgery and cosmetic procedures: what primary care physicians think Dermatol Surg. 2012 Oct; 38(10):1645-51. . View in PubMed

Application of mobile teledermatology for skin cancer screening J Am Acad Dermatol. 2012 Oct; 67(4):576-81. . View in PubMed

J Am Acad Dermatol. 2012 Sep; 67(3):357-62. . View in PubMed

Patient-centered online management of psoriasis: a randomized controlled equivalency trial J Am Acad Dermatol. 2012 Jun; 66(6):948-53. . View in PubMed

Novel approach to utilizing electronic health records for dermatologic research: developing a multi-institutional federated data network for clinical and translational research in psoriasis and psoriatic arthritis Dermatol Online J. 2012 May 15; 18(5):2. . View in PubMed

Why some dermatologists do not practice store-and-forward teledermatology Arch Dermatol. 2012 May; 148(5):649-50. . View in PubMed

Cost-effectiveness analysis of a patient-centered care model for management of psoriasis J Am Acad Dermatol. 2012 Apr; 66(4):563-70. . View in PubMed

Combination treatments for psoriasis: a systematic review and meta-analysis Arch Dermatol. 2012 Apr; 148(4):511-22. . View in PubMed

Coronary artery disease in patients with psoriasis referred for coronary angiography Am J Cardiol. 2012 Apr 01; 109(7):976-80. . View in PubMed

Survey of demographic and educational factors among dermatology chairs and chiefs Cutis. 2012 Apr; 89(4):195-8. . View in PubMed

Crowdsourcing for research data collection in rosacea Dermatol Online J. 2012 Mar 15; 18(3):15. . View in PubMed

Advances in management of atopic dermatitis: new therapies and novel uses of existing treatments Semin Cutan Med Surg. 2012 Mar; 31(1):17-24. . View in PubMed

The effect of academic "misrepresentation" on residency match outcomes Dermatol Online J. 2012 Jan 15; 18(1):1. . View in PubMed

Melanoma: epidemiology, diagnosis, treatment, and outcomes Dermatol Clin. 2012 Jan; 30(1):113-24ix. . View in PubMed

Impact of live interactive teledermatology on diagnosis, disease management, and clinical outcomes Arch Dermatol. 2012 Jan; 148(1):61-5. . View in PubMed

A review of health outcomes in patients with psoriasis Dermatol Clin. 2012 Jan; 30(1):61-72viii. . View in PubMed

Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy PLoS One. 2012; 7(4):e33486. . View in PubMed

Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011 Dermatology. 2012; 225(2):121-6. . View in PubMed

Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011 PLoS One. 2012; 7(12):e52935. . View in PubMed

Health outcomes in atopic dermatitis Dermatol Clin. 2012 Jan; 30(1):73-86viii. . View in PubMed

Nonmelanoma skin cancer Dermatol Clin. 2012 Jan; 30(1):125-39ix. . View in PubMed

Combination systemic therapies in psoriatic arthritis J Dermatolog Treat. 2011 Oct; 22(5):276-84. . View in PubMed

Elephantiasic thyroid dermopathy Am J Med. 2011 Sep; 124(9):e1-2. . View in PubMed

Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis J Dermatol Sci. 2011 Jul; 63(1):1-9. . View in PubMed

Umbilicated erythematous papules in an immunocompromised patient Lancet Infect Dis. 2011 Jun; 11(6):488. . View in PubMed

Effects of video-based, online education on behavioral and knowledge outcomes in sunscreen use: a randomized controlled trial Patient Educ Couns. 2011 May; 83(2):273-7. . View in PubMed

Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010 PLoS One. 2011 Apr 13; 6(4):e17520. . View in PubMed

Psoriasis and hypertension severity: results from a case-control study PLoS One. 2011 Mar 29; 6(3):e18227. . View in PubMed

Current state of acne treatment: highlighting lasers, photodynamic therapy, and chemical peels Dermatol Online J. 2011 Mar 15; 17(3):2. . View in PubMed

Online video improves clinical outcomes in adults with atopic dermatitis: a randomized controlled trial J Am Acad Dermatol. 2011 Mar; 64(3):502-7. . View in PubMed

Health-care delivery methods in teledermatology: consultative, triage and direct-care models J Telemed Telecare. 2011; 17(4):214-6. . View in PubMed

Practice models and challenges in teledermatology: a study of collective experiences from teledermatologists PLoS One. 2011; 6(12):e28687. . View in PubMed

Failure to maximize patient adherence strategies in clinical practice Arch Dermatol. 2010 Dec; 146(12):1430-1. . View in PubMed

A pale version Am J Med. 2010 Sep; 123(9):802-4. . View in PubMed

Evaluation and comparison of store-and-forward teledermatology applications Telemed J E Health. 2010 May; 16(4):424-38. . View in PubMed

Erythema induratum of Bazin Dermatol Online J. 2010 Apr 15; 16(4):1. . View in PubMed

Online, video-based patient education improves melanoma awareness: a randomized controlled trial Telemed J E Health. 2009 Dec; 15(10):992-7. . View in PubMed

Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring Arch Dermatol. 2009 Nov; 145(11):1230-6. . View in PubMed

A national survey to determine an optimal fourth year curriculum for dermatology candidates Dermatol Online J. 2009 Oct 15; 15(10):2. . View in PubMed

Physician workforce for acne care in the United States, 2003 through 2005 Arch Dermatol. 2009 Oct; 145(10):1195-6. . View in PubMed

Digital imaging in dermatology: attitudes, behaviors, and innovations Skin Res Technol. 2009 Aug; 15(3):376-7. . View in PubMed

Reconstruction of the upper aerodigestive tract with the submental artery flap Plast Reconstr Surg. 2009 Feb; 123(2):562-570. . View in PubMed

Follicular eruption on arms and legsPhrynoderma. Arch Dermatol. 2008 Nov; 144(11):1509-14. . View in PubMed

Fate of manuscripts declined by the Journal of the American Academy of Dermatology J Am Acad Dermatol. 2008 Apr; 58(4):632-5. . View in PubMed

Images in HIV/AIDSSweet syndrome and syphilis in an HIV-infected person. AIDS Read. 2008 Mar; 18(3):134-5. . View in PubMed

Economic evaluation of interactive teledermatology compared with conventional care Telemed J E Health. 2007 Apr; 13(2):91-9. . View in PubMed

The efficacy of ultrasound in the diagnosis of long head of the biceps tendon pathology J Shoulder Elbow Surg. 2006 Jan-Feb; 15(1):7-11. . View in PubMed

Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme J Cutan Pathol. 2004 May; 31(5):393-7. . View in PubMed

Please visit Dr. Armstrong's research website: https://armstronglab.usc.edu/

Dr. April Armstrong is Associate Dean of Clinical Research at Keck School of Medicine at USC. She also serves as Director of Clinical Research for the Southern California Clinical and Translational Research Institute (SC CTSI). In the Department of Dermatology at USC, she serves as Vice Chair, Director of Clinical Trials and Outcomes Research, and Director of the Psoriasis Program.

Dr. Armstrong obtained her medical degree from Harvard Medical School and completed dermatology residency at the Harvard Dermatology Residency Program. She also obtained a Master of Public Health degree from Harvard School of Public Health. Prior to joining faculty at the University of Southern California, Dr. Armstrong served as Vice Chair, Director of Clinical Research, and Director of Psoriasis Program at dermatology departments at the University of California Davis and later at the University of Colorado.

For her research focus, Dr. Armstrong is particularly interested in the appropriate use of systemic agents, comparative effectiveness research, technology-enabled healthcare delivery, and comorbidities associated with inflammatory skin diseases. Dr. Armstrong has conducted studies examining how new therapies impact patients’ disease states, quality of life, and their access to medical care. She is also examining how technology-enabled healthcare delivery can be applied to manage patients with chronic dermatological diseases. She is a federally funded investigator with an extensive clinical trial experience, having led or collaborated on over 120 studies. She has authored over 150 peer-reviewed scientific publications and has been an editor for the top pharmacology textbook Principles of Pharmacology. Her work has been supported by the NIH, Patient-Centered Outcomes Research Institute (PCORI), the Agency for Healthcare Research and Quality (AHRQ), the Dermatology Foundation, and the National Psoriasis Foundation.

Dr. Armstrong has held multiple leadership positions at professional societies, serving as a Medical Board of the National Psoriasis Foundation, Councilor to the International Psoriasis Council, Steering Committee Member for Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. Dr. Armstrong is Chair for Teledermatology SIG at the American Telemedicine Association. She also has served on multiple task forces and committees at the American Academy of Dermatology. Dr. Armstrong also has also served on the editorial boards of JAMA Dermatology, Journal of the American Academy of Dermatology, and Telemedicine and eHealth. She was also past President of Sacramento Valley Dermatologic Society.
sc ctsi logoPowered by SC CTSI